| Issue |
J Extra Corpor Technol
Volume 58, Number 2, June 2026
|
|
|---|---|---|
| Page(s) | 172 - 179 | |
| DOI | https://doi.org/10.1051/ject/2025063 | |
| Published online | 19 June 2026 | |
Case Report
Extracorporeal carbon dioxide removal (ECCO2R) in post lung transplant patients
1
Internal Medicine Residents, Department of Health Sciences, Christus Muguerza Health System, UDEM, Monterrey, Nuevo León, México
2
Clinical Director, Lung Transplant Program. Christus Muguerza Alta Especialidad, Monterrey, México
3
Cardiothoracic and Lung Transplant Surgeon, Lung Transplant Program. Christus Muguerza Alta Especialidad, Monterrey, México
4
Infectology Lung Transplant Program, Christus Muguerza Alta Especialidad, Monterrey, México
5
Nephrology of the Critically Ill Patient, Internal Medicine, Internal Medicine Professor, Department of Health Sciences, Christus Muguerza Health System, Monterrey, Nuevo León, México
6
Pulmonary and Critical Care Medicine, Lung Transplant Program, Christus Muguerza Alta Especialidad, Monterrey, México
* Corresponding author: This email address is being protected from spambots. You need JavaScript enabled to view it.
Received:
28
March
2025
Accepted:
12
October
2025
Abstract
Extracorporeal carbon dioxide removal (ECCO2R) has emerged as a promising adjunctive therapy to mitigate hypercapnia and reduce invasive mechanical ventilation (IMV) settings. We present the cases of two post-lung transplant patients with severe hypercapnia and respiratory failure who were successfully treated with the ECCO2R. In both cases, we used a venovenous ECCO2R (V-ECCO2R) system, employing the Prismalung™ oxygenator integrated into a Prismaflex™ continuous renal replacement therapy (CRRT) platform. This technique proved efficacy in correcting hypercapnia, improving ventilatory parameters, and facilitating lung-protective strategies in post-lung transplant patients with respiratory failure. This technique represents a valuable adjunct to conventional mechanical ventilation, particularly in cases where hypercapnia poses a risk to graft function and patient stability. Further studies are warranted to establish optimal patient selection and refine treatment protocols for ECCO2R implementation in critical care settings.
Key words: Extracorporeal carbon dioxide removal / Hypercapnia / Post-lung transplant patient / Respiratory failure
© The Author(s), published by EDP Sciences, 2026
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
